Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05065008 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Roles of Gut Microbiome in UTI Susceptible Women

StatusCompleted
PhaseNot applicable
Started2021-10-18
View on ClinicalTrials.gov ↗

Amendment history

2026-10-01
notable
Trial completed
Primary completion confirmed: September 2026 (last estimated August 2026)
2025-09-04
minor
Study Status v6
Primary completion date2025-08→2026-08
Completion date2025-08→2026-08
2025-06-09
minor
Study Status v5
Re-verified, no change to tracked fields
2024-05-14
notable
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v4
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 1 of 1 site
2023-05-08
minor
Study Status v3
Re-verified, no change to tracked fields
Show 2 earlier versions
2022-01-10
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-12→confirmed 2021-10-18
Study sitesdetails revised at 1 of 1 site
2021-10-11
minor
Study Status, Outcome Measures, Eligibility v1
Secondary endpoints2 entries, revised
Determine the compositional differences of gut microbiome in responders and non-responders after the cranberry juice intake Identify anti-adhesion urinary biomarkers in responders versus non-responders after the cranberry juice intake
2021-09-29
minor
Original filing
Clinical trials on cranberry juice and UTI prevention yielded both positive and negative results for unknown reason. Gut microbiome in women affect the absorption and metabolism of cranberry bioactives. The variation of gut microbiome is a probable mechanism for metabolic polymorphisms and disparity in UTI prevention in women.
Trial Details
NCT Number NCT05065008
Lead Sponsor University of Florida
Collaborators: United States Department of Agriculture (USDA)
Conditions Healthy
Enrollment 152 participants
Start Date 2021-10-18
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-30